The biggest challenge of digitization is the access to data from different systems and the associated data protection laws.
However, “no time” is often only one explanation for the fact that the technical hurdles for implementing digital strategies are perceived as insurmountable. After all, in many companies the rule of three applies: firstly, the integration of isolated IT landscapes is too costly, but secondly, it would be the prerequisite for successful digitization, without which, thirdly, new business models cannot be implemented. “No time” is therefore a synonym for “no money”!
An open-data obligation for machine data, for example, or a targeted promotion of data from the health care sector while respecting data protection is not a technical problem.
Actually, a kind of basic data regulation for the EU and Switzerland would be necessary as a counterweight. Also a data protection that meets the challenges. The concepts in the new data protection regulation DSGVO are not from the last century, but they have not been openly discussed under the new requirements of artificial intelligence, cloud and shared data.
An example from the healthcare sector: One person suffers from high blood pressure, another from diabetes II, and yet another person has to take blood thinners. These are all very treatable diseases of civilization. That such widespread diseases are idiosyncratic can be easily observed with a networked device (wrist tracker) – this constantly measures the values, the data is stored and evaluated by an app. For some people the pressure is too high in the morning, for others in the evening. Some react sensitively to stress, others to noise. For some the values go up after exercise, for others after a beer or a glass of red wine. However, everyone is given a standard medication: once in the morning five or ten milligrams. You don’t have to be a medical doctor to guess this therapy is not individualized. A finer dosage, tailored to each individual, would achieve better results with far fewer side effects. It would increase quality of life and life expectancy and reduce costs. But it just doesn’t work. To measure everyone individually would not be affordable, or would it?
Such an individualized therapy is possible. With modern sensors that permanently transmit values. With reasonable system connections and corresponding access protection and targeted traceability. In this way, one’s own medication could even be compared with the dosages of thousands of other people using clever algorithms and artificial intelligence.
This is just one example of how the effects of digitization will prevail in all areas.